Mads Dalsgaard
Chief Executive Officer,
Cureteq AG
Switzerland
Extensive biopharma experience across R&D and Commercial, including Managing Director Japan. CEO of Cureteq AG, a Swiss based Asset Manager and biotech company builder. Medical Doctor with clinical training in Neurology, DMSc in Neuroscience and an executive MBA from IMD, Switzerland. On the Board of Directors for AptaTargets, Cureteq and it's fully owned subsidiary Oncoteq.
Sessions
-
27-Feb-2024Oncoteq AG
)
){kind=logo}
)
){kind=logo}
){kind=logo}